WASHINGTON (Reuters) May 15 - Generic drugmaker Lannett Co on Thursday said it is working with U.S. regulators to ensure a safe supply of digoxin, following a recall of another version of the drug.
The Food and Drug Administration late last month announced the recall of the Digitek brand of digoxin, sold by Actavis Totowa and distributed by Mylan.
Lannett said it has secured additional active ingredients to meet U.S. demand.
The FDA said the Digitek tablets may contain twice the amount of the active ingredient, which could put patients at risk, including the possibility of death. http://www.medscape.com/viewarticle/574575
Health/life BUMP for FReepers & lurkers. Thanks for the latest, TGirl. (Not much info on who, when, where, how many, etc., etc. may have been affected or perished)
Thanks for the update.